References
- Alfredsson G., Wiesel F.-A., Skett P. Levels of chlorpromazine and its active metabolites in rat brain and the relationship to central monoamine metabolism and prolactin secretion. Psychopharmacology 1977; 53: 13–18
- Al-Waiz M., Ayesh R., Mitchell S. C., Idle J. R., Smith R. L. Disclosure of the metabolic retroversion of trimethylamine N-oxide in humans: a pharmacogenetic approach. Clinical Pharmacology and Therapeutics 1987; 42: 608–612
- Bickel M. H., Weder H. J., Baggiolini M. Vergleich der Metabolitenmuster im Gehin, andern Organen und Harn am Beispiel von Thymoleptica. Helvetica Physiologica et Pharmacologica Acta 1966; 24: C77–C78
- Borromei B. A new antidepressant agent: amitriptyline N-oxide. Advances in Biochemical Psychopharmacology 1982; 32: 43–47
- Dajani R. M., Gorrod J. W., Beckett A. H. In vitro hepatic and extra-heaptic reduction of (-)-nicotine-1-N-oxide in rats. Biochemical Pharmacology 1975; 24: 109–117
- Gruenke L. D., Craig J. C., Klein F. D., Nguyen T.-L., Hitzemann B. A., Holaday J. W., Loh H. H., Braff L., Fischer A., Glick I. D., Hartmann F., Bissell D. M. Determination of chlorpromazine and its major metabolites by gas chromatography/mass spectrometry: application to biological fluids. Biomedical Mass Spectrometry 1985; 12: 707–713
- Heimans R. L. H., Fennessy M. R., Gaff G. A. Some aspects of the metabolism of morphine-N-oxide. Journal of Pharmacy and Pharmacology 1971; 23: 831–836
- Jaworski T. J., Hawes E. M., McKay G., Midha K. K. The metabolism of chlorpromazine N-oxide in the rat. Xenobiotica 1988; 18: 1439–1447
- Jenner P., Gorrod J. W., Beckett A. H. The absorption of nicotine-1-N-oxide and its reduction in the gastro-intestinal tract in man. Xenobiotica 1973; 3: 341–349
- McMahon R. E., Sullivan H. R. Reduction of levopropoxyphene N-oxide to propoxyphene by dogs in vivo and rat liver microsomal fraction in vitro. Xenobiotica 1977; 7: 377–382
- Powis G., Ames M. M., Kovach J. S. Metabolic conversion of indicine N-oxide to indicine in rabbits and humans. Cancer Research 1979; 39: 3564–3570
- Yeung P. K. F., Hubbard J. W., Korchinski E. D., Midha K. K. Radioimmunoassay for the N-oxide metabolite of chlorpromazine in human plasma and its application to a pharmacokinetic study in healthy humans. Journal of Pharmaceutical Sciences 1987; 76: 803–808
- Ziegler D. M. Flavin-containing monooxygenases: catalytic mechanism and substrate specificities. Drug Metabolism Reviews 1988; 19: 1–32